Anticoagulation guidelines
Local Guidelines
The King's Thrombosis centre local guidelines on anticoagulant therapy are available below:
Core anticoagulation guidelines:
Initial management of bleeding in patients who are prescribed apixaban, dabigatran, edoxaban or rivaroxaban:
- Apixaban haemorrhage protocol.pdf
- Dabigatran haemorrhage protocol - Denmark Hill Site.pdf
- Dabigatran haemorrhage protocol - PRUH site.pdf
- Rivaroxaban - Edoxaban haemorrhage protocol - Denmark Hill site.pdf
- Rivaroxaban - Edoxaban haemorrhage protocol - PRUH site.pdf
Guidelines for the management of oral anticoagulation therapy when a patient is due to have a surgical or invasive procedure:
King's peri-operative anticoagulation guideline- King's peri-operative anticoagulation proforma
- Guidelines for the management of antithrombotic therapy in patients undergoing endoscopic procedures.pdf
Guidelines for the management of heparin induced thrombocytopenia:
Manufacturers Summary of Product characteristics
National and International Anticoagulation Guidelines
British Society of Haematology:
- Guidelines on oral anticoagulation with warfarin – 4th edition, 2011
- Safety indicators for inpatient and outpatient oral anticoagulation care – 2007
- Guidelines on the use and monitoring of heparin – 2006
- Management of Heparin Induced Thrombocytopenia - 2nd edition, 2012
- Guidelines on the assessment of bleeding prior to a surgical or invasive procedure – 2007
- Guidelines for the management of patients on oral anticoagulants requiring dental surgery – 2007
- Measurement of non-coumarin anticoagulants and their effects on tests of haemostasis. Guidance from the British Committee for Standards in Haematology - 2014
Royal College of Obstetricians and Gynaecologists:
- RCOG Green-top guideline no.37a: Reducing the risk of thrombosis and embolism during pregnancy and the puerperium – April 2015
- RCOG Green-top guideline no.37b: Thromboembolic disease in pregnancy and the puerperium: acute management – April 2015
ASH VTE guidelines:
- American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy
- American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy
- American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia
- American Society of Hematology 2018 Guidelines for management of venous thromboembolism: treatment of pediatric venous thromboembolism
American College of Chest Physicians:
Anticoagulation Patient Information Leaflets
King's direct oral anticoagulation patient information leaflets:
Apixaban AF patient information leaflet
Dabigatran AF patient information leaflet
Edoxaban AF patient information leaflet
Rivaroxaban AF patient information leaflet
Apixaban VTE patient information leaflet
Dabigatran VTE patient information leaflet
Edoxaban VTE patient information leaflet
Rivaroxaban VTE patient information leaflet
Rivaroxaban superficial vein thrombosis patient information leaflet
-
NPSA: Actions that can make oral anticoagulant therapy safer: Information for patients and carers
(The above is available in the following languages: English, Welsh, Arabic, Bengali, Cantonese, French, Gujerati, Polish, Punjabi, Somalian, Tamil, Urdu)
- Manufacturer's patient information leaflets are available at www.medicines.org.uk
